A recent report on Republican Georgia Sen. David Perdue’s sale of more than $1 million worth of Cardlytics stock in March following an email from the banking company’s CEO contradicts a claim from his office that the transaction was not his decision.
Perdue sold off roughly 20% of his stake in Cardlytics, for which he once sat on the board, after CEO Scott Grimes emailed him in January referencing “upcoming changes,” and soon before the coronavirus pandemic prompted an economic shutdown.
Read more on foxnews.com